Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03891615
Title Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital

lung non-small cell carcinoma


Niraparib + Osimertinib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.